compounded sublingual semaglutide 15ml Drops – Doctor Adam Ozempic | Semaglutide | Weight

Published on October 28th, 2025

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

After 26 weeks (six months), clinical trials of oral semaglutide (Rybelsus) show that: On average, oral semaglutide reduces A1C levels by 1.2%1.4% from an average of 8%

This is expected for any telehealth platform handling PHI, but it's better to confirm its published than to assume

Weeks 1-4: Foundation Phase Appetite suppression begins around week three for most people

The compound's fatty-acid modification introduces an oxidation-sensitive feature beyond standard peptide-bond hydrolysis pathways, so light protection matters more here than for unmodified peptide compounds